van de Schoor, F. R.
Baarsma, M. E.
Gauw, S. A.
Ursinus, J.
Vrijmoeth, H. D.
ter Hofstede, H. J. M.
Tulen, A. D.
Harms, M. G.
Wong, A.
van den Wijngaard, C. C.
Joosten, L. A. B.
Hovius, J. W.
Kullberg, B. J.
Article History
Received: 3 August 2023
Accepted: 31 January 2024
First Online: 16 March 2024
Declarations
:
: None of the authors have received any financial compensation from any of the companies participating in the study. MEB and JWH collaborate with Abbott, Bio-Rad Laboratories, and ZEUS Scientific. Moderna and Pfizer on unrelated projects on LB. FvdS and LABJ collaborate with Hycult Biotech on developing novel diagnostic tests for LB. BJK and LABJ are co-inventors of the Spirofind, an experimental in-house assay for LB, which is owned by Radboudumc and was previously licensed for development to Boulder Diagnostics (Boulder, CO, USA) and subsequently Oxford Immunotec (Oxford, UK) until 2018. The other authors report no potential conflicts of interest.